Revolutionizing Drug Development: The Role Of AI In Protein Folding And Its Impact On The ATMP Industry

In the realm of drug development, the intricacies of protein folding have long posed a significant challenge. The way a protein folds directly impacts its function, and any misfolding can lead to diseases like Alzheimer's, Parkinson's, and cystic fibrosis. Additionally, the field of Advanced Therapy Medicinal Products (ATMPs) has been rapidly evolving, encompassing gene therapies, cell therapies, and tissue-engineered products. Enter artificial intelligence (AI), a game-changer that is transforming the study of protein folding and revolutionizing the ATMP industry.